Nancy Wey-Schopf

Nancy Wey-Schopf is an experienced regulatory affairs professional currently serving as the Director of RAQAC at Osler Diagnostics since August 2023. Prior to this role, Nancy held the position of Director of Regulatory Affairs at Abbott Rapid Diagnostics from April 2019 to October 2024 and served as Director of Diagnostics Regulatory Affairs at Haemonetics from August 2016 to April 2019. Nancy's experience also includes working as Associate Director of Global Regulatory Affairs at Abbott Molecular from March 2011 to July 2016 and Manager of Global Regulatory Affairs at Baxter Healthcare from December 2008 to July 2011. Nancy Wey-Schopf holds a PhD in Molecular Biology from Northwestern University and a BS in Biochemistry from the University of Illinois Urbana-Champaign.